Company: GRCE
Filing Date: 2025-07-28
Form Type: DEF 14A
Source: 0001140361-25-027456
Chunk: 38

Company: Grace Therapeutics, Inc.
Filing Date: 2025-07-28
Form: DEF 14A
Chunk 38
---
,019 |     |           |
| Carrie D’Andrea                     
 Vice President, Clinical Operations |      |     | 2025 |         |     | 286,000 |         |     |  49,763 |         |     |         85,800 |         |     |   421,563 |
|                                     | 2024 |     |      | 248,250 |     |         |  52,250 |     |         |  82,500 |     |                | 383,000 |     |           |

| (1) | Calculated in accordance with Financial Accounting Standards Board (the “FASB”) Accounting Standards Codification (“ASC”) Topic 718, “Compensation — Stock Compensation.” The fair value of stock options is estimated at the grant date using the Black-Scholes option pricing model, which uses various inputs including fair value of the common stock at the grant date, expected term, historical volatility, risk-free interest rate and expected dividend yields of the common stock. Although the assumptions used reflect management’s best estimates, they involve inherent uncertainties based on market conditions generally outside of the Company’s control. See “—Narrative to Summary Compensation Table—Stock Option Awards Granted for Fiscal Year 2025” below for a description of the material terms pursuant to which this compensation was awarded. |

| (2) | See “—Narrative to Summary Compensation Table—Non-Equity Incentive Plan Compensation Awarded for Fiscal Year 2025” below for a description of the material terms of the program pursuant to which this compensation was awarded. |

Narrative to Summary Compensation Table Base Salaries for Fiscal Year 2025 The annual base salary for each of our NEOs for Fiscal Year 2025 is listed in the table below:

| Named Executive Officer                             |     | 2025 Base Salary 
              ($) |
| Prashant Kohli,Chief Executive Officer              |     |          500,000 |
| Amresh Kumar,Vice President, Program Management     |     |          286,000 |
| Carrie D’Andrea,Vice President, Clinical Operations |     |          286,000 |

Non-Equity Incentive Plan Compensation Awarded for Fiscal Year 2025 Messrs. Kohli and Kumar and Ms. D’Andrea are each eligible to receive an annual performance bonus based on the achievement of corporate objectives as determined by our Board of Directors or Compensation Committee. Each executive officer is assigned a target bonus expressed